TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T73756	Ephrin type-B receptor 2	B2G3VF	5-[1-Furan-2-yl-meth-(Z)-ylidene]-2-(4-methoxy-phenylamino)-thiazol-4-one	Investigative	135418649	C15H12N2O3S	300.3	COC1=CC=C(C=C1)N=C2NC(=O)/C(=C/C3=CC=CO3)/S2	IC50 = 230000 nM	Non binder
T73756	Ephrin type-B receptor 2	BBV1J0	3-(4-Methoxy-phenyl)-1-[2-(2-methyl-1H-indol-3-yl)-ethyl]-1-pyridin-4-ylmethyl-thiourea	Investigative	2157766	C25H26N4OS	430.6	CC1=C(C2=CC=CC=C2N1)CCN(CC3=CC=NC=C3)C(=S)NC4=CC=C(C=C4)OC	IC50 = 250000 nM	Non binder
T73756	Ephrin type-B receptor 2	BCHG98	5-[(Z)-1-(3,4-Dimethoxyphenyl)methylidene]-2-(4-hydroxyanilino)-1,3-thiazol-4-one	Investigative	135438929	C18H16N2O4S	356.4	COC1=C(C=C(C=C1)/C=C\\2/C(=O)NC(=NC3=CC=C(C=C3)O)S2)OC	IC50 = 220000 nM	Non binder
T73756	Ephrin type-B receptor 2	BFQ1N6	3-[3-(2-Fluoro-phenyl)-[1,2,4]oxadiazol-5-yl]-N-(3-isopropoxy-propyl)-propionamide	Investigative	22431119	C17H22FN3O3	335.4	CC(C)OCCCNC(=O)CCC1=NC(=NO1)C2=CC=CC=C2F	IC50 = 201000 nM	Non binder